Advertisement

Cytotechnology

, Volume 37, Issue 1, pp 13–22 | Cite as

Explants of porcine coronary artery in culture: A paradigm for studying the influence of heparin on vascular wall cell proliferation

  • M. DufresneEmail author
  • R. Warocquier-Clérout
Article

Abstract

Explant cultures of porcine coronary artery provided a coculture model, used as a paradigm of arterial wall in contact with vascular prosthesis which allowed the study of spatial and temporal changes in cell phenotype. First cells emerging from the explant had an endothelial phenotype monitored by cytoimmunostaining. Percentages of anti-smooth muscle α-actin labelled cells were assessed at early and late phase by flow cytofluorometric analysis to control the effect of heparin. At 100 μg ml-1, no effect on α-actin labelled cell growth has been detected. This result contrasted with the inhibition of monolayer cell cultures. At 500 μg ml-1, the proliferation of smooth muscle cells was reduced. This explant system should be useful for testing drugs susceptible to interfere with restenosis.

coronary artery explant culture endothelial cells heparin proliferation smooth muscle cells 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramovitch R, Neeman M, Reich R, Stein I, Keshet E, Abraham J, Solomon A and Marikovsky M (1998) Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Lett 425:441–447.PubMedCrossRefGoogle Scholar
  2. Ahn YK, Jeong MH, Kim JW, Kim SH, Cho JH, Park CS, Juhng SW, Park JC and Kang JC (1999) Preventive effects of the heparin-coated stent on restenosis in the porcine model.Catheter Cardiovasc Interv48:324–330.PubMedCrossRefGoogle Scholar
  3. Asakawa H and Kobayashi T (1999) The effect of coculture with human smooth muscle cells on the proliferation, the IL-1 beta secretion, the PDGF production and tube formation of human aortic endothelial cells.Cell Biochem Funct17:123–130.PubMedCrossRefGoogle Scholar
  4. Baumbach A, Oberhoff M, Lerch M, Schroder S, Meisner C, Rubsamen K and Karsch KR (2000) Local delivery of a low molecular weight heparin following stent implantation in the pig coronary artery.Basic Res Cardiol 95: 173–178.PubMedCrossRefGoogle Scholar
  5. Bono F, Rigon P, Lamarche I, Savi P, Salel V and Herbert JM(1997) Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells.Biochem J326: 661–668.PubMedGoogle Scholar
  6. Christ G, Wojta J and Binder BR (1992) Distribution of smooth muscle cells derived urokinase in cocultures with endothelial cells.Fibrinolysis 6:139–143.Google Scholar
  7. Christen T, Bochaton-Piallat ML, Neuville P, Rensen S, Redard M, van Eys G and Gabbiani G (1999) Cultured porcine coronary artery smooth muscle cells. A new model with advanced differentiation.Circ Res85:99–107.PubMedGoogle Scholar
  8. Delmolino LM and Castellot JJ (1997) Heparin suppresses sgk, an early response gene in proliferating vascular smooth muscle cells.J Cell Physiol 173:371–379.PubMedCrossRefGoogle Scholar
  9. Dodge B, Lu X and d'Amore PA (1993) Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.J Cell Biochem53:21–31.PubMedCrossRefGoogle Scholar
  10. Dufresne M, Warocquier-Clérout R and Sigot-Luizard MF (1994) Cell phenotype characterization in vascular organotypic culture. J Mater Sci5: 824–829.CrossRefGoogle Scholar
  11. Fager G, Camejo G and Bondjers G (1992) Heparin-like glycosaminoglycans influence growth and phenotype of human arterial smooth muscle cells in vitro. I. Evidence for reversible binding and inactivation of the PDGF by heparin. In Vitro Cell Dev Biol 28:168–175.Google Scholar
  12. Fillinger MF, O'Connor SE and Wagner R (1993) The effect of endothelial cell coculture on smooth muscle cell proliferation. J Vasc Surg17: 1058–1068.PubMedCrossRefGoogle Scholar
  13. Finking G, Wolkenhauer M, Lenz C and Hanke H (2000) Post-injury ex vivomodel to investigate effects and toxicity of pharmacological treatment in rings of rabbit aortic vessels. ALTEX 17: 67–74.PubMedGoogle Scholar
  14. Goodwin SC, Yoon HC, Wong GC, Bonilla SM, Vedantham S and Arora LC (2000) Percutaneous delivery of a heparinimpregnated collagen stent-graft in a porcine model of atherosclerotic disease.Invest Radiol35:420–425.PubMedCrossRefGoogle Scholar
  15. Gross DR (1985) Animal Models in Cardiovascular Research. Boston, Martinus Nijhoff, pp.537–547.Google Scholar
  16. Gulba D (1999) Differentiation of low molecular weight heparin in acute coronary syndromes: an interventionalist's perspective. Semin Thromb Hemost25:123–127.PubMedCrossRefGoogle Scholar
  17. Hardhammer PA, van Beusekom HM, Emanuelsson SH, Hofma SH, Albertssson PA, Verdouw PD, Boersma E, Serruys PW and van der Giessen WJ (1996) Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries.Ciculation93:423–430.Google Scholar
  18. Ishihara M, Saito Y, Yura H, Ono K, Ishikawa K, Hattori H, Akaike T and Kurita A (2000) Heparin-carrying polystyrene to mediate cellular attachment and growth via interaction with growth factors.J Biomed Mater Res50:144–152.PubMedCrossRefGoogle Scholar
  19. Kang SS, Gosselin C, Ren D and Greisler HP (1995) Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by Fibroblast Growth Factor-1 plus heparin delivered from fibrin glue suspensions.Surgery 118:280–287.PubMedCrossRefGoogle Scholar
  20. Kinard F, Sergent-Engelen T, Trouet A, Remacle C and Schneider YJ (1997) Compartmentalized coculture of porcine arterial endothelial and smooth muscle cells on a microporous membrane. In Vitro Cell Dev Biol 33:92–103.Google Scholar
  21. Koo EW and Gotlieb AI (1992)The use of organ cultures to study vessel wall pathology.Scanning Microscopy 6:827–835.PubMedGoogle Scholar
  22. Laemmel E, Penhoat J, Warocquier-Clérout R and Sigot-Luizard MF (1998) Heparin immobilized on proteins usable for arterial prostheses coating: growth inhibition of smooth muscle cells.J Biomed Mater Res 39:446–452.PubMedCrossRefGoogle Scholar
  23. Malinda KM, Ponce L, Kleinman HK, Shackelton LM and Millis AJ (1999) Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells.Exp Cell Res 250:168–173.PubMedCrossRefGoogle Scholar
  24. Oberhoff M, Novak S, Herdeg C, Baumbach A, Kranzhofer AGoogle Scholar
  25. Bohnet A, Horch B, Hanke H, Haase KK and Karsch KR (1998) Local and systemic delivery of low molecular weight heparin stimulates the reendothelialization after balloon angioplasty. Cardiovasc Res38:751–762.PubMedCrossRefGoogle Scholar
  26. Saunders KB and D'Amore PA (1992) An in vitromodel for cell- cell interactions. In Vitro Cell Dev Biol28:521–528.Google Scholar
  27. Seifert B, Romaniuk P and Groth T (1996) Bioresorbable, heparinized polymers for stent coating: In vitrostudies on heparinization efficiency, maintenance of anticoagulant proprerties and improvement of stent haemocompatibility.J Mater Sci 7:465–469.CrossRefGoogle Scholar
  28. Shi Y, O'Brien JE, Fard A and Zalewski A (1996) Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation94:1655–1663.PubMedGoogle Scholar
  29. Shulman RI (2000) Assessment of low-molecular-weight heparin trials in cardiology.Pharmacol Ther 87:1–9.PubMedCrossRefGoogle Scholar
  30. Voyta JC, Via DP, Butterfield CE and Zetter BR (1984) Identi-fication and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein.J Cell Biol99:2034–2040.PubMedCrossRefGoogle Scholar
  31. Xu CB, Stavenow L and Pessah-Rasmussen H (1993) Interactions between cultured bovine arterial endothelial and smooth muscle cells; further studies on the effects of injury and modification of the consequences of injury.Artery20:163–179.PubMedGoogle Scholar
  32. Yang TT, Sinai P and Kain SR (1996)An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells.Anal Biochem 241: 103–108.PubMedCrossRefGoogle Scholar
  33. Zubilewicz T, Ski J, Bourriez A, Terlecki P, Guinault AM, Muscatelli-Groux B, Michalak J, Melliere D, Becquemin JP and Allaire E (2001) Injury in vascular surgery-the intimal hyperplastic response.Med Sci Monit7:316–324.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  1. 1.Laboratoire de Biologie Cellulaire ExpérimentaleUMR 6600, Université de Technologie de CompiègneCompiègneFrance
  2. 2.Laboratoire de Biologie Cellulaire ExpérimentaleUMR 6600, Université de Technologie de CompiègneCompiègneFrance

Personalised recommendations